Apoptosis induction serves as a crucial mechanism contributing to the therapeutic effectiveness of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) cases with EGFR mutations. Here, EGFR is linked to non-small cell lung carcinoma.